Lentitek Ltd

DataGardener
live
Micro

Lentitek Ltd

sc633239•Private Limited With Share Capital

Floor 3, 1-4 Atholl Crescent, Edinburgh, EH38HA

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

12/06/2019

Company Age

6 years

Directors

4

Employees

4

SIC Code

21100

Risk

low risk

Company Overview

Registration, classification & business activity

Lentitek Ltd (sc633239) is a private limited with share capital incorporated on 12/06/2019 (6 years old) and registered in edinburgh, EH38HA. The company operates under SIC code 21100 and is classified as Micro.

Lentitek is developing solutions to help amazing therapies get to more people. gene therapies, and gene-modified cell therapies such as car-t are proving themselves as incredible life changing and life saving therapies. however they face an issue with the production yield of the viral vector. ...

Private Limited With Share Capital
SIC: 21100
Micro
Incorporated 12/06/2019
EH38HA
4 employees

Financial Overview

Total Assets

£579.3K

Liabilities

£88.3K

Net Assets

£490.9K

Cash

£0

Key Metrics

4

Employees

4

Directors

74

Shareholders

1

Patents

Board of Directors

4
A
adam grant inche
director
L
leif crombie anderson
director
G
gabriel directors ltd
director
M
michael lesley roberts
director

Filed Documents

38
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:02-02-2026
Resolution
Category:Resolution
Date:19-12-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:18-12-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-07-2025
Resolution
Category:Resolution
Date:04-07-2025
Capital Allotment Shares
Category:Capital
Date:03-07-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-04-2025
Memorandum Articles
Category:Incorporation
Date:28-02-2025
Resolution
Category:Resolution
Date:28-02-2025
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:22-02-2025
Capital Allotment Shares
Category:Capital
Date:22-02-2025
Capital Allotment Shares
Category:Capital
Date:22-02-2025
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:13-12-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:08-08-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:13-06-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:25-09-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:15-06-2023
Capital Alter Shares Subdivision
Category:Capital
Date:15-05-2023
Memorandum Articles
Category:Incorporation
Date:12-05-2023
Capital Allotment Shares
Category:Capital
Date:12-05-2023
Resolution
Category:Resolution
Date:12-05-2023
Resolution
Category:Resolution
Date:12-05-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:11-05-2023
Appoint Corporate Director Company With Name Date
Category:Officers
Date:11-05-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:22-07-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:16-06-2022
Accounts With Accounts Type Unaudited Abridged
Category:Accounts
Date:24-03-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-06-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:17-06-2021
Termination Secretary Company With Name Termination Date
Category:Officers
Date:13-05-2021
Accounts With Accounts Type Dormant
Category:Accounts
Date:13-05-2021
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:24-02-2021
Capital Alter Shares Subdivision
Category:Capital
Date:22-02-2021
Capital Allotment Shares
Category:Capital
Date:22-02-2021
Memorandum Articles
Category:Incorporation
Date:18-02-2021
Resolution
Category:Resolution
Date:18-02-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:11-06-2020
Incorporation Company
Category:Incorporation
Date:12-06-2019

Innovate Grants

1

This company received a grant of £197223.0 for Next-Generation Lentiviral Production To Enable Advanced Therapies Including Car-T Immunotherapy For Childhood Malignancies. The project started on 01/09/2024 and ended on 31/03/2026.

Risk Assessment

low risk

International Score

Future Factor

good

Performance Rating

Accounts

Typemicro-entity accounts
Due Date31/03/2027
Filing Date02/02/2026
Latest Accounts30/06/2025

Trading Addresses

Floor 3, 1-4 Atholl Crescent, Edinburgh, EH38HARegistered

Related Companies

1
reactec limited
live

Contact

Floor 3, 1-4 Atholl Crescent, Edinburgh, EH38HA